Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ROUTINE ROENTGENOGRAPHY AND BONE SCAN FOLLOWING BREAST CANCER

This article was originally published in The Gray Sheet

Executive Summary

ROUTINE ROENTGENOGRAPHY AND BONE SCAN FOLLOWING BREAST CANCER treatment does not improve survival, two studies published in the May 25 Journal of the American Medical Association find. Based on the results, both studies recommend against routine follow-up of breast cancer patients with chest roentgenography and bone scan; one of the studies also recommends against routine use of liver echography and laboratory tests to detect distant metastases.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT002372

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel